Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Firms Could Gain From Proposed EU Risk Management Plan Revision

This article was originally published in The Tan Sheet

Executive Summary

AESGP and EFPIA are set to submit a joint proposal to the EMA that would streamline risk management plans for long-marketed products and provide uniform treatment for products approved under differing regulatory procedures.

You may also be interested in...

EU Pharmacovigilance Fees Could Cripple Drug Firms, Says Pharma Industry

Fees set to be introduced to cover the cost of the European Medicines Agency’s part in improving drug safety could impose a huge burden on the EU pharmaceutical industry and lead to the closure of smaller firms, the industry says.

EU Post-Market Safety Proposals Stir Concerns About Cost, Complexity

Even as a proposal to improve the European Union pharmacovigilance system for marketed drugs moves one step closer to adoption, industry is increasingly concerned about its cost and complexity.

Good Vigilance Practice Guideline Sought For More Consistent PSUR Reviews

The development of good vigilance practices will be the focus of both European Union and International Conference on Harmonization working groups





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts